WASHINGTON - U.S. Food and Drug Administration approved the first RSV vaccine for pregnant women so their babies will be born with protection against the respiratory infection.
RSV is notorious for filling hospitals with wheezing babies every fall and winter. The FDA cleared Pfizer’s maternal vaccination to guard against a severe case of RSV when babies are most vulnerable — from birth through 6 months of age.
The next step is for the Centers for Disease Control and Prevention to issue recommendations for using the vaccine, called Abrysvo, during pregnancy.
Vaccinations for older adults, also at high risk, are getting underway this fall using the same Pfizer shot plus another from competitor GSK. (The AP 08/22/23)
No comments:
Post a Comment